• AA
  • Share

Could Metformin Reduce Cancer Death Risk?

Metformin, one of the most widely prescribed diabetes drugs, may have a new, hidden benefit: reducing the risk of dying from some cancers in postmenopausal women with type 2 diabetes, HealthDay reports.

These findings are from a new study in International Journal of Cancer, which found that for women with type 2 diabetes and cancer who are taking Metformin, the risk of dying from cancer was the same as diabetes-free women with cancer. In women with cancer and diabetes who weren’t taking Metformin, their risk of dying from cancer appeared to be  45% higher.

Read complete story.

You may also like

  • Sticker Shock: An Inconvenient Truth About Healthcare Prices

    Diabetes patients already feel the daily health burden of their disease. However, the rising costs of their medical care are also taking a toll. While endocrinologists understand the problems and have solutions, getting those solutions implemented is the ultimate challenge. Irl B. Hirsch, MD, professor of medicine at the University of Washington in Seattle runs…

  • Endocrine Society Applauds CMS on CGM Coverage

    The Endocrine Society praised the decision to extend access to therapeutic continuous glucose monitors (CGMs) to older Americans on intensive insulin therapy for diabetes. The Centers for Medicare & Medicaid Services (CMS) announced new coverage criteria for CGM devices Thursday. The guidance states that all Medicare individuals who have type 1 or type 2 diabetes…

Find more in